about
Neuronal nicotinic receptors: from protein structure to functionNicotinic acetylcholine receptors containing the α7-like subunit mediate contractions of muscles responsible for space positioning of the snail, Helix pomatia L. tentacle.Medicinal chemistry approaches for the treatment and prevention of Alzheimer's disease.No involvement of nicotinic receptors in the facilitation of acetylcholine outflow in mouse cortex in the presence of neostigmine and atropineSubtype-specific actions of beta-amyloid peptides on recombinant human neuronal nicotinic acetylcholine receptors (alpha7, alpha4beta2, alpha3beta4) expressed in Xenopus laevis oocytes.PICK1 interacts with alpha7 neuronal nicotinic acetylcholine receptors and controls their clustering.Quantification of alpha4beta2* nicotinic receptors in the rat brain with microPET and 2-[18F]F-A-85380Alpha4beta2 nicotinic receptor status in Alzheimer's disease using 123I-5IA-85380 single-photon-emission computed tomography.Distribution and development of nicotinic acetylcholine receptor subtypes in the optic tectum of Rana pipiens.Competition, Selectivity and Efficacy of Analogs of A-84543 for Nicotinic Acetylcholine Receptors with Repositioning of Pyridine Nitrogen.Quantification of nicotinic acetylcholine receptors in the human brain with PET: bolus plus infusion administration of 2-[18F]F-A85380.Nicotinic acetylcholine receptor-mediated responses in medial vestibular and prepositus hypoglossi nuclei neurons showing distinct neurotransmitter phenotypes.Heart rate and blood pressure variability in patients with myasthenia gravisRadiation dosimetry of the α4β2 nicotinic receptor ligand (+)-[18F]flubatine, comparing preclinical PET/MRI and PET/CT to first-in-human PET/CT results.A spatial covariance (123)I-5IA-85380 SPECT study of α4β2 nicotinic receptors in Alzheimer's disease.Rat neuronal nicotinic acetylcholine receptors containing alpha7 subunit: pharmacological properties of ligand binding and function.Enhancement of nicotinic receptors alleviates cytotoxicity in neurological disease models.Mutational consequences of aberrant ion channels in neurological disorders.Functional contribution of the alpha7 subunit to multiple subtypes of nicotinic receptors in embryonic chick sympathetic neurones.A molecular dynamics study of catestatin docked on nicotinic acetylcholine receptors to identify amino acids potentially involved in the binding of chromogranin A fragments.Relationship between the increased cell surface alpha7 nicotinic receptor expression and neuroprotection induced by several nicotinic receptor agonists.Decreased cerebral α4β2* nicotinic acetylcholine receptor availability in patients with mild cognitive impairment and Alzheimer's disease assessed with positron emission tomography.Chronic nicotine administration increases NGF-like immunoreactivity in frontoparietal cerebral cortex.Nicotinic acetylcholine receptor distribution in Alzheimer's disease, dementia with Lewy bodies, Parkinson's disease, and vascular dementia: in vitro binding study using 5-[(125)i]-a-85380.Evidence of association between smoking and alpha7 nicotinic receptor subunit gene in schizophrenia patients.Desensitization of catecholamine release. The novel catecholamine release-inhibitory peptide catestatin (chromogranin a344-364) acts at the receptor to prevent nicotinic cholinergic tolerance.[18 F]Nifene test-retest reproducibility in first-in-human imaging of α4β2* nicotinic acetylcholine receptors.Comparison of the regional expression of nicotinic acetylcholine receptor alpha7 mRNA and [125I]-alpha-bungarotoxin binding in human postmortem brain.[125/123I]IPH: a radioiodinated analog of epibatidine for in vivo studies of nicotinic acetylcholine receptors.Nicotinic receptors in dementia of Alzheimer, Lewy body and vascular types
P2860
Q28214998-E0611064-BB61-4FC1-A68C-2A09C09F90EAQ34323415-AEA7E500-2BE6-4BC5-9446-5DD3261F31DDQ34993154-E24D6876-E209-49E0-B834-04AADB844159Q35042611-84A5E83E-E7CC-4F98-9359-7BA42FEEE62DQ35545131-3DFB6E6B-AEC9-403B-A9DE-C7618845F75FQ35848221-6712F0DA-0EA8-4E7B-AC32-66AA39D98AC3Q36066101-FD7AD3EC-841A-457B-9460-6B9C9855A37FQ36143289-A47D3F77-9658-4D13-962D-FC91351C73A6Q36490997-1BF080E7-91E5-436B-8A1B-B1039CD03B75Q36543626-4D8A9F7C-4383-4122-8028-5D4C30219906Q36662874-C32E66BF-0A0E-471B-B286-D8197DC03AF7Q37041678-781C343B-0BC2-40B5-AF3C-403D928AF9DBQ37210369-E2187906-4F66-40FC-8BB8-5F0F04D72D8FQ37358441-A42ACC24-9CC7-40F3-A665-A23A392B0B5DQ37371552-AA8B1E52-9179-4B63-B8FD-2583FB131E6CQ37728112-174A0A44-F763-4B61-9788-344A18DBAD30Q38068415-8FF95868-F69A-4B57-8D59-626BFAAAB6B1Q38239544-E1961640-D8F0-4E79-9D54-3619EBFC6311Q38337408-935407AF-61EF-4D28-AC17-6817A8E166BAQ38995155-6C429B1E-9321-4059-B8A7-99B0CEEDCFBEQ42514322-E8588045-B22F-4040-81BF-06901B121BE0Q43811406-4402CBFF-3A6F-46AD-BFAE-FD9183CA2370Q44556491-56893545-C96F-46CA-865D-1C2AB4A49260Q44573142-8BA651C5-8B72-4A89-9FD8-1EF824E5A0A9Q44853711-6AB3843F-5384-4928-939B-37520A108D96Q46691940-967A58F9-E1CF-4AED-B740-B2C5402EC8AFQ48262668-6949EC74-9790-442B-931C-794EF1B575CAQ48615437-512EA990-CAB9-4B4A-A845-70E7F7D1BDB4Q48654667-59BA3387-22D0-47C5-B1D7-7333B8627D26Q57950473-8F27CD46-3759-4B0F-BD25-39306B8009A9
P2860
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Neuronal nicotinic receptor subtypes.
@en
type
label
Neuronal nicotinic receptor subtypes.
@en
prefLabel
Neuronal nicotinic receptor subtypes.
@en
P2093
P2860
P1476
Neuronal nicotinic receptor subtypes.
@en
P2093
P2860
P304
P356
10.1111/J.1749-6632.1995.TB17467.X
P407
P577
1995-05-01T00:00:00Z